MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, PLYX has $5,170K in assets. $605K in debts. $5,143K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
854.55%
Quick Ratio
854.55%
Cash Ratio
850.08%
Debt to Asset Ratio
11.70%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Other current assets
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
5,143
Other current assets
27
Total current assets
5,170
Total assets
5,170
Accounts payable
470
Due to related party
91
Accrued expenses related party
23
Accrued expenses and other current liabilities
21
Total current liabilities
605
Total liabilities
605
Common stock 0.0001 par value 560,000,000 shares authorized 47,343,297 and 41,151,571 shares issued and outstanding at december 31, 2025 and 2024, respectively
5
Additional paid-in capital
104,195
Accumulated deficit
-99,635
Total stockholders equity
4,565
Total liabilities and stockholders equity
5,170
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$5,143K Other current assets$27K Total current assets$5,170K Total assets$5,170K Total liabilities andstockholders equity$5,170K Total stockholdersequity$4,565K Total liabilities$605K Accumulated deficit-$99,635K Additional paid-in capital$104,195K Total currentliabilities$605K Common stock 0.0001 parvalue 560,000,000...$5K Accounts payable$470K Due to related party$91K Accrued expenses related party$23K Accrued expenses andother current...$21K

Polaryx Therapeutics, Inc. (PLYX)

Polaryx Therapeutics, Inc. (PLYX)